Bimodal modulation by nicotine of anxiety in the social interaction test: Role of the dorsal hippocampus

Behavioral Neuroscience

Volumn 112, Issue 6, 1998, Pages 1423-1429

  File, Sandra E ^a,b   Kenny, Paul J ^a   Ouagazzal, Abdel Mouttalib ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; DRUG VEHICLE; MECAMYLAMINE; NEUROTRANSMITTER; NICOTINE TARTRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIGHT EXPOSURE; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; RAT; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANIMALS; AROUSAL; BRAIN MAPPING; DOMINANCE, CEREBRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; HIPPOCAMPUS; MALE; NICOTINE; RATS; RATS, INBRED STRAINS; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT;

EID: 0032407322     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.112.6.1423     Document Type: Article

References (13)

1. Brazell, M. P., Mitchell, S. N., & Gray, J. A. (1991). Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study. Neuropharmacology, 30, 823-833.
2. Brioni, J. D., O'Neill, A. B., Kim, D. J., & Decker, M. W. (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. European Journal of Pharmacology, 238, 1-8.
3. Cao, W., Burkholder, T., Wilkins, L., & Collins, A. C. (1993). A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology Biochemistry and Behavior, 45, 803-809.
4. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. European Journal of Pharmacology, 234, 91-99.
5. Costall, B., Kelly, M. E., Naylor, R. J., & Onaivi, E. S. (1989). The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacology Biochemistry and Behavior, 33, 197-203.
6. Curran, H. V., Schifano, F., & Lader, M. (1991). Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology, 103, 83-90.
7. Decker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., Raszkiewicz, J. L., Kang, C. H., Kim, D. J., Giardina, W. J., Wasicak, J. T., Garvey, D. S., Williams, M., & Arneric, S. P. (1994). (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities. II. In vivo characterization. Journal of Pharmacology and Experimental Therapeutics, 270, 319-328.
8. Falter, U., Gower, A., & Gobert, J. (1991). Anxiogenic effects of scopolamine observed in rats in the elevated plus-maze. In M. Briley & S. E. File (Eds.), New concepts in anxiety (pp. 332-337). London: Macmillan Press.
9. Matta, S. G., McAllen, K. M., & Sharp, B. M. (1990). Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine. Journal of Pharmacology and Experimental Therapeutics, 252, 623-630.
10. Meltzer, H. L. T., & Rosecrans, J. A. (1981). Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine. Pharmacology Biochemistry and Behavior, 15, 21-26.
11. Meyers, R. D. (1975). Blood-brain barrier: Techniques for the intracerebral administration of drugs. In L. L. Iversen, S. D. Iversen, and S. H. Snyder (Eds.), Handbook of psychopharmacology (pp. 1-28). New York: Plenum Press.
12. O'Neill, A. B., & Brioni, J. D. (1994). Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. Pharmacology Biochemistry and Behavior, 49, 755-757.
13. Paxinos, G., & Watson, C. H. (1986). The rat brain in stereotaxic coordinates (2nd ed.). London: Academic Press.